Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Jan 12, 2012 | SVP, GM - Oncology | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Jun 01, 2011 | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,091 | -- | -- | ||
| Feb 01, 2011 | SVP, General Manager | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Feb 01, 2011 | SVP, General Manager | Form 3/A | Amendment to an Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Sep 15, 2010 | Senior VP, CTO | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- | |
| Apr 27, 2010 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 2,091 | -- | -- | |
| Nov 12, 2009 | SVP - General Manager | Form 3 | Initial Statement of Beneficial Ownership of Securities | -- | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.